Literature DB >> 22126451

Hericium erinaceus suppresses LPS-induced pro-inflammation gene activation in RAW264.7 macrophages.

Young-Ock Kim1, Sang-Won Lee, Chung-Hun Oh, Yun-Hee Rhee.   

Abstract

The aim of this study was to investigate the anti-inflammatory properties of each fraction of Hericium erinaceus (HE). The ethanol extract from HE was partitioned with different solvents in the order of increasing polarity. The treatment with 10-100 μg/mL of each fraction did not reduce RAW 264.7 cell viability except ethyl acetate fraction. Among the various extracts, the chloroform fraction showed the most potent activity against nitric oxide (NO), prostaglandin E(2) (PGE(2)) and reactive oxygen species (ROS). The western blotting and reverse transcriptase polymerase chain reaction (RT-PCR) analyses revealed that chloroform fraction from HE (CHE) significantly reduced the protein level of iNOS and cyclooxygenase-2 (COX-2) or mRNA levels of iNOS in lipopolysaccharide-induced macrophages. Furthermore, CHE inhibited the translocation of nuclear factor (NF)-κB p65 subunit, phsophorylation of I-κB, extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK) in a dose-dependent manner. Furthermore, the activation of both activator protein-1 (AP-1) and NF κB in the nucleus were abrogated by CHE with luciferase assay. In conclusion, these results indicate that CHE may provide an anti-inflammatory effect by attenuating the generation of excessive NO, PGE(2), and ROS and by suppressing the expression of pro-inflammatory genes through the inhibition of NF-κB and JNK activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22126451     DOI: 10.3109/08923973.2011.633527

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  7 in total

1.  Pleurotus eryngii Ameliorates Lipopolysaccharide-Induced Lung Inflammation in Mice.

Authors:  Junya Kawai; Tsugunobu Andoh; Kenji Ouchi; Satoshi Inatomi
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-01       Impact factor: 2.629

2.  The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice.

Authors:  Chunfen Mo; Ling Wang; Jie Zhang; Satoshi Numazawa; Hong Tang; Xiaoqiang Tang; Xiaojuan Han; Junhong Li; Ming Yang; Zhe Wang; Dandan Wei; Hengyi Xiao
Journal:  Antioxid Redox Signal       Date:  2013-09-17       Impact factor: 8.401

3.  Hericium erinaceus Inhibits TNF-α-Induced Angiogenesis and ROS Generation through Suppression of MMP-9/NF-κB Signaling and Activation of Nrf2-Mediated Antioxidant Genes in Human EA.hy926 Endothelial Cells.

Authors:  Hebron C Chang; Hsin-Ling Yang; Jih-Hao Pan; Mallikarjuna Korivi; Jian-You Pan; Meng-Chang Hsieh; Pei-Min Chao; Pei-Jane Huang; Ching-Tsan Tsai; You-Cheng Hseu
Journal:  Oxid Med Cell Longev       Date:  2015-12-28       Impact factor: 6.543

4.  Genotoxicity profile of erinacine A-enriched Hericium erinaceus mycelium.

Authors:  I-Chen Li; Yen-Lien Chen; Wan-Ping Chen; Li-Ya Lee; Yueh-Ting Tsai; Chin-Chu Chen; Chin-Shuh Chen
Journal:  Toxicol Rep       Date:  2014-11-15

5.  Chondroprotective Effects of a Standardized Extract (KBH-JP-040) from Kalopanax pictus, Hericium erinaceus, and Astragalus membranaceus in Experimentally Induced In Vitro and In Vivo Osteoarthritis Models.

Authors:  Md Mahbubur Rahman; Hyun-Kyu Kim; Seong-Eun Kim; Myung-Jin Kim; Do-Hyung Kim; Hak Sung Lee
Journal:  Nutrients       Date:  2018-03-15       Impact factor: 5.717

6.  Lion's Mane Mushroom, Hericium erinaceus (Bull.: Fr.) Pers. Suppresses H2O2-Induced Oxidative Damage and LPS-Induced Inflammation in HT22 Hippocampal Neurons and BV2 Microglia.

Authors:  Naufal Kushairi; Chia Wei Phan; Vikineswary Sabaratnam; Pamela David; Murali Naidu
Journal:  Antioxidants (Basel)       Date:  2019-08-01

7.  Anti-Inflammatory Effect of Erinacine C on NO Production Through Down-Regulation of NF-κB and Activation of Nrf2-Mediated HO-1 in BV2 Microglial Cells Treated with LPS.

Authors:  Li-Yu Wang; Chin-Shiu Huang; Yu-Hsuan Chen; Chin-Chu Chen; Chien-Chih Chen; Cheng-Hung Chuang
Journal:  Molecules       Date:  2019-09-12       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.